Literature DB >> 20464093

[Tuberous sclerosis: evaluation of myofibroblasts in cutaneous angiofibromas - case report].

Erick Gomes Perez1, Lívia Ribeiro Paranaíba, Paulo Rogério Bonan, Julian Miranda Orsi Júnior, Adriano Macedo de Oliveira, Hercílio Martelli Júnior.   

Abstract

Tuberous sclerosis is a rare autosomal dominant disorder. Myofibroblasts are cells with a hybrid phenotype between fibroblasts and smooth muscle cells. The objective of this study is to describe clinical and histopathological characteristics of tuberous sclerosis and to conduct an immunohistochemical evaluation of myofibroblasts in cutaneous angiofibromas present in this condition. Lesion sections removed were stained with hematoxylin-eosin and Masson's trichrome. Immunohistochemistry against alpha-SMA was done to determine the presence of myofibroblasts, and the reaction was negative. Since alpha-SMA is a specific marker for myofibroblasts, this result suggests that myofibroblasts are not involved in cutaneous angiofibromas present in the tuberous sclerosis case reported.

Entities:  

Mesh:

Year:  2010        PMID: 20464093     DOI: 10.1590/s0365-05962010000100013

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  2 in total

1.  Tuberous Sclerosis with Severe Cutaneous Manifestation and Multiples Facial Angiofibromas.

Authors:  Natália Galvão Garcia; Marina Lara de Carli; Denise Tostes Oliveira; Cléverson Teixeira Soares; Noé Vital Ribeiro Júnior; Felipe Fornias Sperandio; João Adolfo Costa Hanemann
Journal:  Head Neck Pathol       Date:  2016-05-02

2.  Nanostructured Cellulose-Gellan-Xyloglucan-Lysozyme Dressing Seeded with Mesenchymal Stem Cells for Deep Second-Degree Burn Treatment.

Authors:  Carolina Maria Costa de Oliveira Souza; Clayton Fernandes de Souza; Bassam Felipe Mogharbel; Ana Carolina Irioda; Celia Regina Cavichiolo Franco; Maria Rita Sierakowski; Katherine Athayde Teixeira de Carvalho
Journal:  Int J Nanomedicine       Date:  2021-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.